Today: 15 May 2026
Browse Category

Earnings Reports 30 January 2026

Merck stock rises as markets wobble — what to watch before the Feb. 3 earnings call

Merck stock rises as markets wobble — what to watch before the Feb. 3 earnings call

Merck shares rose 1.2% to $109.64 Friday afternoon, outperforming a falling S&P 500. Health care stocks attracted buyers as inflation data came in hotter than expected and Donald Trump named Kevin Warsh as Federal Reserve chair. Investors are watching for Merck’s Feb. 3 earnings call, with focus on 2026 guidance and Keytruda sales trends.
30 January 2026
···
Eaton stock slides late Friday as ETN investors weigh AI data-center push, earnings next week

Eaton stock slides late Friday as ETN investors weigh AI data-center push, earnings next week

Eaton shares fell 0.9% to $351.32 Friday after U.S. inflation data and a new Fed nomination rattled markets. The company, active in AI power-supply, will report Q4 earnings Feb. 3 and discuss plans to spin off its Mobility business by Q1 2027. Trading volume topped the 50-day average Thursday as Eaton closed up 2.03%. Investors await 2026 guidance and updates on electrical segment orders.
30 January 2026
····
Colgate-Palmolive stock price jumps 5% after earnings beat and upbeat 2026 sales forecast

Colgate-Palmolive stock price jumps 5% after earnings beat and upbeat 2026 sales forecast

Colgate-Palmolive shares rose 5.2% to $89.70 Friday after the company beat Q4 profit forecasts and projected 2026 net sales growth of 2% to 6%. A $794 million after-tax impairment charge pushed GAAP results to a quarterly loss. Q4 net sales reached $5.23 billion, with adjusted earnings of 95 cents per share. Demand held steady in Latin America and Europe, while North American volumes stayed flat.
30 January 2026
···
Air Products stock jumps 6% after earnings beat guidance — what APD investors watch next

Air Products stock jumps 6% after earnings beat guidance — what APD investors watch next

Air Products and Chemicals shares rose 6.2% to $271.89 after fiscal Q1 adjusted EPS reached $3.16, beating estimates and topping guidance. Revenue climbed 6% to $3.1 billion. The company held its FY2026 adjusted EPS forecast at $12.85–$13.15 and expects capex near $4 billion. Helium weakness continued to weigh on volumes and pricing, especially in Asia.
30 January 2026
··
Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher shares edged up 0.1% to $219.83 Friday after steep losses earlier in the week. The company reported Q4 revenue of $6.84 billion and adjusted EPS of $2.23, with 2026 earnings guidance in line with analyst forecasts. Investors remain cautious amid weak academic research funding and recent stock swings. Vanguard disclosed an 8.63% stake in Danaher as of Dec. 31.
30 January 2026
·····
Moog stock price jumps on record quarter, raised 2026 outlook and dividend boost

Moog stock price jumps on record quarter, raised 2026 outlook and dividend boost

Moog shares jumped 6.4% to $306.57 after the company posted record quarterly sales of $1.1 billion and raised its 2026 outlook. Bookings reached $2.3 billion, pushing backlog up 30% to $3.3 billion. The company lifted its quarterly dividend 3% to $0.30 per share. Free cash flow turned negative as Moog increased inventory and faced tariff pressures on margins.
30 January 2026
··
SoFi stock price whipsaws after earnings: SOFI slides even as it posts a $1 billion quarter

SoFi stock price whipsaws after earnings: SOFI slides even as it posts a $1 billion quarter

SoFi Technologies shares fell 8% to $22.48 Friday after volatile trading, as investors reacted to strong Q4 profits and raised 2026 forecasts. The company reported record loan originations of $10.5 billion and a 78% jump in financial services income. SoFi now expects 2026 adjusted net revenue of $4.655 billion and adjusted EBITDA near $1.6 billion. Next earnings report is set for April 28.
30 January 2026
···
AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie shares rose about 1% Friday, closing near $222.73 ahead of its Feb. 4 earnings report and first 2026 guidance. Investors are watching Botox pricing risks after Medicare listed it for price negotiations, and new aesthetics data from Paris. The stock dropped 2.35% Wednesday, ending a five-day rally. Goldman Sachs kept a neutral rating with a $223 target.
30 January 2026
···
Brookfield Renewable stock jumps on 2025 results, 5% dividend hike and Google hydro deal

Brookfield Renewable stock jumps on 2025 results, 5% dividend hike and Google hydro deal

Brookfield Renewable Corporation shares rose 6.5% to $41.88 in New York after reporting higher 2025 results and raising its quarterly dividend to $0.392 per share. The company announced a major hydro power deal with Google and added 8,000 megawatts of new capacity. Brookfield also launched a $400 million equity program to fund buybacks. 2025 FFO fell to $628 million from $794 million, citing asset sales and reorganization.
30 January 2026
·····
Boston Scientific stock price climbs as Penumbra deal stays in focus ahead of Feb. 4 earnings

Boston Scientific stock price climbs as Penumbra deal stays in focus ahead of Feb. 4 earnings

Boston Scientific shares rose 1.7% to $93.87 Friday afternoon, outpacing a broader market decline. The move comes ahead of the company’s Feb. 4 earnings report and conference call, its first since announcing a $14.5 billion deal to acquire Penumbra. Investors are watching for details on the acquisition’s impact and the 2026 outlook.
30 January 2026
···
Bloom Energy stock price slips again as BE pulls back ahead of Feb. 5 earnings

Bloom Energy stock price slips again as BE pulls back ahead of Feb. 5 earnings

Bloom Energy shares fell 3.4% to $151.18 Friday, extending a volatile slide after Barclays initiated coverage with an equal-weight rating and a price target suggesting a steep drop. The stock swung between $146.60 and $161.59 as traders weighed new analyst reports and data-center power demand. Plug Power, FuelCell Energy, and Ballard Power Systems also declined. Bloom’s quarterly results are due Feb. 5.
30 January 2026
···
Verizon stock jumps nearly 10% on earnings, buyback plan and 2026 cash outlook

Verizon stock jumps nearly 10% on earnings, buyback plan and 2026 cash outlook

Verizon shares rose 9.8% to $43.73 Friday after the company reported 616,000 new postpaid phone subscribers and issued strong 2026 profit guidance. The board approved a $25 billion share buyback and quarterly dividend of $0.7075. Verizon closed 2025 with $131.1 billion in unsecured debt. CEO Dan Schulman cited network reliability investments and the recent Frontier merger as key to future growth.
30 January 2026
··
Credit Acceptance stock jumps 8% after earnings beat — loan collections back in focus

Credit Acceptance stock jumps 8% after earnings beat — loan collections back in focus

Credit Acceptance shares jumped 8.2% to $488.41 after posting adjusted quarterly EPS of $11.35, beating forecasts. Revenue rose to $579.9 million, but the company reported a moderate decline in forecasted loan collections and repurchased $191.4 million in stock. Net income for the quarter was $122 million. Management flagged weaker loan volumes and a $35.8 million contingent legal loss.
30 January 2026
··
Liberty Broadband stock jumps as Charter earnings ease broadband subscriber fears

Liberty Broadband stock jumps as Charter earnings ease broadband subscriber fears

Liberty Broadband shares rose 6.1% to $47.25 after Charter Communications reported a smaller-than-expected broadband subscriber loss in Q4. Charter lost 119,000 internet customers, beating forecasts, but revenue missed estimates at $13.60 billion. Charter’s stock gained 6.3%. Liberty’s valuation remains tied to Charter ahead of their planned merger, expected by June 2027.
30 January 2026
···
Sandisk stock swings higher after blowout forecast as AI-storage demand bites

Sandisk stock swings higher after blowout forecast as AI-storage demand bites

Sandisk shares jumped 9% to $586.80 after the company forecast third-quarter profit and revenue well above Wall Street estimates. Quarterly earnings and sales surged, driven by strong AI infrastructure demand and a 64% rise in datacenter revenue. Sandisk extended its flash-memory supply deal with Kioxia through 2034. Investors await management’s webcast for updates on supply constraints.
30 January 2026
····
Bradesco stock dips in Sao Paulo as Brazil rate-cut talk builds, earnings next week in focus

Bradesco stock dips in Sao Paulo as Brazil rate-cut talk builds, earnings next week in focus

Bradesco’s preferred shares (BBDC4) fell 0.4% to 21.35 reais Friday, mirroring a 0.9% drop in the Ibovespa index. Bradesco ADRs slid 1.9% to $4.07 in New York. Investors await Bradesco’s Q4 earnings on Feb. 5, focusing on loan demand and credit provisions. Brazil’s central bank held the Selic rate at 15%, signaling possible cuts in March but stressing caution.
30 January 2026
···
Palo Alto Networks (PANW) stock ticks up after Chronosphere deal closes as traders eye next earnings

Palo Alto Networks (PANW) stock ticks up after Chronosphere deal closes as traders eye next earnings

Palo Alto Networks shares rose about 0.5% to $177.15 Friday after the company finalized its acquisition of Chronosphere. Financial terms were not disclosed, though a previous agreement valued the deal at $3.35 billion. Investors await Palo Alto’s earnings report for details on integration costs and future guidance. The stock had dropped 4.1% in the prior session.
30 January 2026
···
1 … 76 77 78 79 80 … 248

Stock Market Today

  • Live Cattle Futures Rise Amid Strong Cash Trade and Export License Renewals
    May 15, 2026, 3:42 PM EDT. Live cattle futures gained $1.3 to $1.55 by midday, supported by cash sales reaching $260 in the South and $408-$415 dressed in the North. Feeder cattle futures increased $1.15 to $3.42, with the CME Feeder Cattle Index up 9 cents to $373.23 on May 13. China renewed export licenses for US beef plants after recent expirations, potentially boosting trade. USDA reported federally inspected cattle slaughter at 108,000 head Thursday, up 4,000 from last week but down 34,262 versus last year. Wholesale boxed beef prices showed mixed movements: Choice down $1.41 to $388.86 and Select up $1.62 at $390.62. Market activity reflects cautious optimism amid ongoing health concerns and export developments.

Latest articles

AT&T’s Starlink Defense: Verizon, T-Mobile Join Rare Satellite Push to Kill Dead Zones

AT&T’s Starlink Defense: Verizon, T-Mobile Join Rare Satellite Push to Kill Dead Zones

15 May 2026
AT&T, Verizon, and T-Mobile announced plans to jointly build a satellite-based network to eliminate U.S. wireless dead zones, aiming to connect ordinary phones directly to satellites. The move follows the FCC’s approval of EchoStar’s $40 billion spectrum sale to SpaceX and AT&T. The carriers have an agreement in principle but have not finalized terms. AT&T reported $31.5 billion in Q1 revenue and $126.4 billion in net debt.
Ambev Stock Faces Reality Check After Brazil Beer Boom and UBS Sell Call

Ambev Stock Faces Reality Check After Brazil Beer Boom and UBS Sell Call

15 May 2026
Ambev’s São Paulo shares fell 0.25% to 15.73 reais Friday, despite UBS raising its target price but maintaining a Sell rating. First-quarter profit rose 2.1% to 3.89 billion reais, with Brazil Beer volumes hitting a record and net revenue up 9.6%. Cash flow surged 162.5% to 3.16 billion reais. Consolidated cash cost of goods sold per hectoliter climbed 8.5%.
Pfizer Inc Looks to India for Growth—But Proof Remains Elusive for Investors

Pfizer Inc Looks to India for Growth—But Proof Remains Elusive for Investors

15 May 2026
Pfizer is increasing investment in India for cancer drugs, obesity treatments, and vaccines as it seeks growth beyond COVID-era sales. The company reported Q1 revenue of $14.5 billion, up 5%, but expects a $1.5 billion hit this year from generic competition. Shares fell 1.8% to $25.29 in New York trading. In Europe, Pfizer won expanded approval for its hemophilia drug Hympavzi.
BigBear.ai Stock Drops as Investors Question Defense-AI Growth

BigBear.ai Stock Drops as Investors Question Defense-AI Growth

15 May 2026
BigBear.ai shares fell about 5% to $4.16 Friday afternoon after reporting flat first-quarter revenue of $34.4 million and a wider adjusted EBITDA loss of $9.9 million. Backlog rose 14% to $281.9 million, boosted by a $53 million classified contract. The company kept its 2026 revenue forecast at $135 million to $165 million. Gross margin improved to 34.0% from 21.3% a year earlier.
Go toTop